Results 191 to 200 of about 13,237 (299)

Clinical Presentation of Cat Scratch Disease in Pediatric Patients-A Single-Center Study. [PDF]

open access: yesTurk Arch Pediatr
Öcal-Demir S   +3 more
europepmc   +1 more source

Targeted Degradation of eEF2K by a Structure‐Guided PROTAC Strategy for the Treatment of Triple‐Negative Breast Cancer

open access: yesAdvanced Science, EarlyView.
This study developed an eEF2K‐targeting PROTAC, A6, that efficiently degrades eEF2K in TNBC cells, inhibiting tumor growth in vitro and in vivo. To enhance tumor‐specific delivery, we engineered A6@ZIF‐8, a pH‐sensitive nanocarrier, which improved drug accumulation at tumor sites, offering a promising therapeutic strategy for TNBC through targeted ...
Shijun Cao   +10 more
wiley   +1 more source

Multifocal Osteomyelitis in an Adolescent Patient With Cat Scratch Disease. [PDF]

open access: yesCase Rep Infect Dis
Topçu B   +4 more
europepmc   +1 more source

Cat-Scratch Disease in the United States, 2005–2013

open access: diamond, 2016
Christina A. Nelson   +2 more
openalex   +1 more source

Cascade Therapy of Periodontitis via Sequential Release of Ribosome‐Targeting Antimicrobial Peptide and Irisin From a Multifunctional MOF‐Based System

open access: yesAdvanced Science, EarlyView.
This study presents a novel strategy for periodontitis treatment by co‐delivering a membrane‐ and ribosome‐targeting antimicrobial peptide GF and Irisin through a pH‐responsive metal‐organic framework. The system enables sequential release, providing rapid antibacterial action, anti‐inflammatory and antioxidative effects, as well as promoting bone ...
Yan Chen   +10 more
wiley   +1 more source

Unusual presentation of cat scratch disease: case report. [PDF]

open access: yesEur J Clin Microbiol Infect Dis
Aslan Tuncay S   +12 more
europepmc   +1 more source

Optic neuritis secondary to bartonellosis (cat scratch disease by bartonella quintana): a case report

open access: gold
Luiz Felipe Mota Freitas   +5 more
openalex   +1 more source

ROS‐Responsive Wedelolactone Hydrogel Promotes Intervertebral Disc Repair by Disrupting the NF‐κB–LCN2 Inflammatory Feedback Loop

open access: yesAdvanced Science, EarlyView.
A mechanically robust, ROS‐responsive hydrogel is engineered to treat intervertebral disc degeneration by targeting the NF‐κB–LCN2 inflammatory feedback loop. By delivering wedelolactone specifically within oxidative niches, this system disrupts macrophage–disc cell crosstalk.
Zimei Wu   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy